CIHR, Genome BC announce $5.4 million for microbiome research

NewsGuard 100/100 Score

The University of British Columbia today welcomed the announcement of $5.4 million in funding from the Canadian Institutes of Health Research (CIHR) and Genome British Columbia for research into how micro-organisms affect human health.

Two projects, led by UBC researchers Brett Finlay and Deborah Money, were part of seven grants totaling $15.5 million announced today in Toronto by federal Health Minister Leona Aglukkaq.

"We are surrounded by microbes and yet we know relatively little about them," says John Hepburn, UBC Vice President Research and International. "The emerging field of microbiomics will contribute new knowledge to improve the health of Canadians and people around the world. We are grateful for this significant investment from the federal government and Genome BC."

Finlay's project will examine the impact intestinal microbes have on the immune system and their potential connection to asthma. It is supported by $2.5 million from CIHR and $625,000 from Genome BC. Finlay is a professor of microbiology at UBC's Michael Smith Laboratories. His team consists of researchers from UBC and the Child & Family Research Institute.

Money's project will use the latest genome sequencing tools to determine what contributes to a healthy balance of microorganisms in the vagina, and how an imbalance may be associated with preterm delivery, genital tract infection and overall reproductive health. It is supported by

Source: University of British Columbia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis